Use of Consumer Sleep Technology to Treat Shift Work Disorder

NCT ID: NCT05186233

Last Updated: 2025-06-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

63 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-18

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examine the effectiveness of a personalized light exposure schedule for Shift Work Disorder (SWD) in night shift workers compared to a non-personalized light exposure schedule.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will be randomized into each condition (n = 25) in a 1:1 ratio. Variables of interest, dim light melatonin onset (DLMO) and shift work disorder (SWD) symptoms, will be assessed before and after the intervention, which will last two weeks. All participants (N=50) will be asked to wear an Apple Watch for two weeks leading up to an in-lab visit. Activity data collection from the Apple Watch will be processed through a mathematical model of the human circadian pacemaker (previously validated in SWD) to generate estimates of DLMO. This two-week period is followed by a 27-hour laboratory visit for pre-treatment assessment of DLMO (hourly saliva melatonin samples over 24 hours). At the end of this visit, participants will receive an orientation to the SHIFT mobile application, where they will be able to assess their prescribed light exposure schedule.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Shift-work Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Non-personalized light condition

Participants will receive light exposure recommendations from the SHIFT mobile application based on their habitual sleep schedule. Participants will follow these recommendations over the course of two weeks.

Group Type ACTIVE_COMPARATOR

Phototherapy

Intervention Type BEHAVIORAL

Light exposure recommendations provided by SHIFT mobile application

Personalized light condition

Participants will receive light exposure recommendations from the SHIFT mobile application based on their activity levels. Participants will follow these recommendations over the course of two weeks.

Group Type EXPERIMENTAL

Phototherapy

Intervention Type BEHAVIORAL

Light exposure recommendations provided by SHIFT mobile application

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Phototherapy

Light exposure recommendations provided by SHIFT mobile application

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants must work at least 2 night shifts a week
* Participants must have night shifts starting between 18:00 and 02:00 and lasting 8 to 12 hours
* Participants must have maintained this night shift schedule for at least 6 months
* Participants must have Shift Work Disorder, diagnosed based on ICSD-3 criteria

Exclusion Criteria

* Medical history of central nervous system disorders
* Medical history of other sleep disorders
* Diagnosis of an unstable major medical condition medical chart review
* Dependence on alcohol (≥ 4 beverages a day)
* Heavy tobacco use (≥ 10 cigarettes per day)
* Recreational drug use
* Use of medications impacting central nervous system functioning
* Caffeine use in excess of 5-6 servings (\~ 600mg) per day
* Pregnancy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

American Academy of Sleep Medicine

OTHER

Sponsor Role collaborator

Henry Ford Health System

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Philip Cheng

Assistant Scientist

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Henry Ford Columbus Medical Center

Novi, Michigan, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

15108

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Optimizing Sleep Health in Nurses
NCT05965609 RECRUITING NA
Deaf CBT-TS to Reduce Suicide Risk
NCT07279363 NOT_YET_RECRUITING NA
Effect of WBT for CI With Depression
NCT06968013 RECRUITING NA